New Technologies Enhance the Formulation of Highly Potent Drugs
Advances in solid and liquid formulation techniques are providing more options.

Fluorination Remains Key Challenge in API Synthesis
Safer fluorinating reagents and access to GMP fluorination capabilities remain challenges in API synthesis.

Advertisement: Vcaps® Plus capsules offer better performance compared with first-generation HPMC capsules. Now there is an exciting new way for you to find the right capsule for your specific trial, project, or study needs. the Vcaps® Plus Expert Kit.This complimentary kit offers R&D professionals a fast and comprehensive hands-on experience with Vcaps® Plus technology. Learn more

Economic Growth Stalls in Brazil
Brazil's pharmaceutical industry is optimistic, but is the pharmaceutical market growing steadily or showing signs of instability?

Advertisement: Natoli introduces the NP-RD20, an automated single station, cGMP and CE compliant mobile lab press. Use the RD20 to manufacture single tablets or test tablet parameters during research and development. It features programmable precompression parameters and dwell time, as well as Data Acquisition capabilities to collect and track test results, including compression curve and elasticity in single, bi-layer, and multi-layer tablets. Learn more

MPI Research Acquires Jasper Clinical Research & Development
Addition of clinical trials company expands MPI Research capabilities to include human Phase I testing.

Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
Bristol-Myers Squibb announced that they have reached an agreement with F-star Alpha, giving Squibb the exclusive option to acquire F-star's HER2-targeted breast and gastric cancer treatment.

Advertisement: Systematic and Efficient Analytical Method Development for A Speedy Clinical Product Development On Demand Webcast To Register Free: www.pharmtech.com/Efficient

Yale and Gilead Extend Sequencing Initiative
The Yale School of Medicine and Gilead will continue their research on cancer targets for a minimum of three additional years.

Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
New research will focus on a superfamily of protein receptors linked to various diseases.

Advertisement: Developing a Comprehensive Tool Kit for Microbial Identification November 18, 2014 at 11:00 AM EST Click here to Register free.

Unum Raises $12 million in Funding for ACTR-Based Cancer Treatment
Unum Therapeutics raised $12 million in Series A funding for its development of antibody-coupled T cell receptors (ACTRs) for the treatment of nonspecific tumor cells.

Meissner's Filtration System Allows Scalability
Filtration system for gamma irradiation cycles allows scalability.

Despite AbbVie Snub, Shire Says it Will Double Sales by 2020
Shire announces it will expand its orphan drug portfolio and is ready for future M&A discussions.

J&J Speeds Ebola Vaccine Development and Expands Production
Johnson & Johnson is collaborating with WHO and others on clinical testing, development, production, and distribution of an Ebola vaccine.

GSK Accelerates Ebola Vaccine Development
GSK's investigational Ebola vaccine is in Phase I safety trials.